Financial Results and Agreements - Research Report on Lincoln Financial Group, Genworth, Omega, ING, and Healthcare Realty
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, January 1, 2014 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Lincoln National Corp. (NYSE: LNC), Genworth Financial Inc. (NYSE: GNW), Omega Healthcare Investors Inc. (NYSE: OHI), ING Groep NV (NYSE: ING), and Healthcare Realty Trust Inc. (NYSE: HR). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Lincoln National Corp. Research Report
On October 30, 2013, Lincoln National Corp. (Lincoln Financial Group) reported its financial results for Q3 2013 with revenues of $3.0 billion, up 1.9% YoY. Lincoln's net income for Q3 2013 was $337 million or $1.23 per diluted share, versus $428 million or $1.51 per diluted share in Q3 2012. Q3 2013 income from operations was $367 million or $1.34 per diluted share, versus $362 million or $1.27 per diluted share in Q3 2012. Dennis R. Glass, President and CEO of Lincoln Financial Group, said, "Lincoln delivered another quarter of strong earnings growth driven by strong sales, positive net flows and favorable equity markets. Long-term ROE development is being helped by the sales growth of re-priced products, the change in new business mix to higher return products and significant share repurchase activity. The ability to sell more products at higher prices demonstrates the capacity of our franchise to build long-term value. In addition, our new $4 billion variable annuity living benefit reinsurance agreement is evidence of our industry leading innovation and commitment to product risk diversification." The Full Research Report on Lincoln National Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Genworth Financial Inc. Research Report
On October 29, 2013, Genworth Financial Inc. (Genworth) reported its financial results for Q3 2013. Genworth's net income was $108 million or $0.22 per diluted share in Q3 2013, compared to $35 million or $0.07 per diluted share in Q3 2012. Net operating income for Q3 2013 was $119 million or $0.24 per diluted share, compared to $111 million or $0.22 per diluted share in Q3 2012. Tom McInerney, President and CEO, said, "Genworth is moving forward and rebuilding shareholder value through solid operating performance from our divisions, the increasing impact of long term care rate actions and continued achievement of key milestones. We have increased our cash balance, established a new credit line, and addressed our near term debt maturities, which have strengthened our balance sheet and increased financial flexibility." The Full Research Report on Genworth Financial Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Omega Healthcare Investors Inc. Research Report
On October 31, 2013, Omega Healthcare Investors Inc. (Omega) reported its financial results for Q3 2013, with total operating revenues of $103.3 million, reflecting a growth of 18.6% YoY. Omega also declared Funds from Operations (FFO) available to common stockholders of $70.3 million or $0.59 per common share during the quarter, which also includes a $2.3 million provision for uncollectible straight-line accounts receivable and $1.5 million of non-cash stock-based compensation expense. The Full Research Report on Omega Healthcare Investors Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
ING Groep NV Research Report
On November 1, 2013, ING Groep NV (ING) reported that it has entered into an agreement with the Dutch State on the unwinding of the Illiquid Assets Back-Up Facility (IABF). According to the Company, the facility was established in 2009, in order to reduce the risk and uncertainty for ING from a portfolio of US Alt-A mortgage securities. ING informed that market developments now authorize the unwinding of the facility, along with selling the securities, with a cash profit for the Dutch State. Ralph Hamers, CEO of ING Group, said, "While we are grateful for the support the Dutch State extended to us in 2009, we are pleased that today we can announce the end of the Alt-A arrangement. Over the past years we have worked hard to make ING stronger and simpler and to limit risks. We are looking ahead to take ING through the last phase of our restructuring and work on further focusing our company on serving our customers." The Full Research Report on ING Groep NV - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Healthcare Realty Trust Inc. Research Report
On October 30, 2013, Healthcare Realty Trust Inc. (Healthcare Realty) reported its financial results for Q3 2013, with revenues of $84.8 million, up 10.2% YoY, and net income attributable to common stockholders of $19.8 million, up 239.9% YoY. Among the few other highlights of the quarter- Healthcare Realty purchased two medical office buildings totaling 286,000 square feet for a total purchase price of $77.5 million; in September 2013, Healthcare Realty successfully purchased the orthopedic surgical facility in Springfield, Missouri for $102.6 million; and it also declared a dividend of $0.30 per common share, which is 88.2% of normalized FAD. The Full Research Report on Healthcare Realty Trust Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner
More by this Source
Global Cell Therapy - Technologies, Markets and Companies
Jan 16, 2014, 14:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.